Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Native reptiles alter their foraging in the presence of the olfactory cues of invasive mammalian predators.

Royal Society open science·2018
Same author

Caries Diagnosis in Dental Practices: Results From Dentists in a Brazilian Community.

Operative dentistry·2018
Same author

Judgment of the Quality of Restorative Care as Predictors of Restoration Retreatment: Findings from the National Dental PBRN.

JDR clinical and translational research·2017
Same author

In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Variability of isometric and isotonic leg exercise: Utility for detection of submaximal effort.

Journal of occupational rehabilitation·2013
Same author

Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
10:34

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes

Published on: February 22, 2017

Quantitation of HIV-1 Entry Cofactor Expression.

J L Riley1, R G Carroll

  • 1Walter Reed Army Institute of Research, Rockville, MD.

Methods in Molecular Medicine
|March 8, 2011
PubMed
Summary
This summary is machine-generated.

Human immunodeficiency virus type 1 (HIV-1) entry into CD4+ T-lymphocytes requires the CD4 receptor and an additional cofactor. The α-chemokine receptor fusin/CXCR4 and three β-chemokine receptors (CCR2b, CCR3, CCR5) have been identified as crucial HIV-1 entry cofactors.

More Related Videos

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
13:13

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques

Published on: September 25, 2018

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

Related Experiment Videos

Last Updated: Jun 3, 2026

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
10:34

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes

Published on: February 22, 2017

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
13:13

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques

Published on: September 25, 2018

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • HIV-1 infection initiates via CD4 receptor binding on T-lymphocytes.
  • CD4 expression alone is insufficient for HIV-1 entry, indicating a need for cofactors.
  • The identity of these essential entry cofactors was previously unknown.

Purpose of the Study:

  • To identify the cellular cofactor(s) required for HIV-1 entry.
  • To elucidate the mechanism of HIV-1 cell entry beyond CD4 binding.
  • To characterize the role of chemokine receptors in HIV-1 pathogenesis.

Main Methods:

  • Investigated HIV-1 entry into CD4+ T-lymphocytes.
  • Assessed the permissiveness of non-human cells expressing CD4 for HIV-1 entry.
  • Identified specific chemokine receptors functioning as HIV-1 entry cofactors.

Main Results:

  • The α-chemokine receptor fusin/CXCR4 was identified as the entry cofactor for T-cell line-tropic HIV-1 isolates.
  • Three β-chemokine receptors, CCR2b, CCR3, and CCR5, were subsequently identified as additional HIV-1 entry cofactors.
  • This research rapidly advanced the understanding of HIV-1 cellular tropism.

Conclusions:

  • HIV-1 entry into target cells is a multi-step process requiring both the CD4 receptor and specific chemokine receptors.
  • CXCR4, CCR2b, CCR3, and CCR5 act as critical cofactors for HIV-1 entry, influencing viral tropism.
  • The identification of these cofactors provides key insights into HIV-1 pathogenesis and potential therapeutic targets.